Pay in 4 interest-free payments of $6.64 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
A Phase 2 trial (NCT01311518) was designed to test RGN-352 in ~75 heart attack patients, but was placed on FDA clinical hold in 2011 due to manufacturing (GMP) compliance issues at the contract site not safety concerns with the drug itself
Protocols vary based on the condition being treated acute injuries typically involve a more intensive initial phase, followed by a maintenance dose
Products tested by an independent laboratory Exclusively pure compounds without additives Worldwide Delivery Warning This product is not intended for human or veterinary use
5-Amino-1MQ full chemical name 5-Amino-1-Methylquinolinium is a small molecule compound belonging to the 1-methylquinolinium (1MQ) scaffold family
Read on to learn how you can ensure your B12 level is sufficient and what to do if its not
US$ 26.98
US$ 28.92
US$ 23.80
US$ 26.63
US$ 28.27
US$ 24.22
US$ 26.10
US$ 24.20
US$ 22.78
US$ 25.59
US$ 23.94
US$ 23.01
US$ 20.70
US$ 24.83
US$ 23.83
US$ 23.17
